SA
Healthcare & Life Sciences
Sagimet
United Statessagimet.com
Sagimet is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Sagimet
Sagimet is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Sagimet is a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors to treat diseases associated with fatty acid overproduction, including acne, metabolic dysfunction-associated steatohepatitis (MASH), and certain FASN-dependent tumors.
Explore Sagimet's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.